Maria Fardis

CIK 1559231 · President and CEO · last filed 2026-06-09

Maria Fardis is a President and CEO who has filed 30 SEC Form 4 insider transactions across 3 companies since 2016. The most recent filing, for CRSP, was dated Jun 9, 2026. Current disclosed insider exposure totals $1.2M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.22M

Companies

3

Total Filings

30

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CRSP Director $49.80 $0 5 2026-06-09
IOVA President and CEO 298,786 $4.08 $1.22M $0 12 2021-01-06
IOVANCE BIOTHERAPEUTICS, INC. (LBIO) Delisted President and CEO 550,000 $0 3 2016-08-19

Recent Filings

30 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-06-09 CRSP Grant (A) $0 EDGAR
2025-06-06 CRSP Grant (A) $0 EDGAR
2024-05-31 CRSP Grant (A) $0 EDGAR
2023-06-09 CRSP Grant (A) $0 EDGAR
2022-06-10 CRSP Grant (A) $0 EDGAR
2021-01-06 IOVA Grant (A) $0 EDGAR
2020-06-02 IOVA Tax (F) −1,894 -$62.7K EDGAR
2020-05-04 IOVA Tax (F) −1,894 -$60.6K EDGAR
2020-04-03 IOVA Tax (F) −1,494 -$41.7K EDGAR
2020-03-04 IOVA Tax (F) −1,321 -$47.5K EDGAR
Showing 110 of 30
Page 1 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.